Therefore, AMPK inhibition reversed ASP4132-induced anti-NSCLC cell activity, suggesting that AMPK activation was required for ASP4132-induced anti-NSCLC cell activity. This evidence concerns the gene PRKAA1 and non-small cell lung carcinoma.